Raju Sunagar

Biography

Dr. Raju Sunagr is an senior scientist working at Ella Foundation, Hyderabad. Currently involved in development of live attenuated vaccines and diagnostics for intercellular bacterial pathogens. Also exploring bacteriophage derived lytic enzymes as an novel antimicrobials to treat MDR bacterial pathogens.Experienced Postdoctoral Fellow with a demonstrated history of working in various vaccine development programs. Familiar in mucosal immunology, host immune response to various pathogens. Current research focused on next generation vaccine designing.

Research Interest

Vaccine Development to Control Streptococcal Infections: The human pathogen Streptococcus pyogenes, commonly referred to as group A streptococcus (GAS), causes severe autoimmune diseases such as post-infectious sequelae-rheumatic fever (RF) and rheumatic heart disease (RHD). The development of a group A streptococcal (GAS) vaccine has focused on the M protein, a major virulence factor. Antibodies against the amino terminal domain of the M protein are generally protective but only provide type-specific immunity.